|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Neuroradiology |
1 From the Section of Diagnostic Radiology, Department of Clinical Physiopathology (M. Mascalchi, C.T., N.V.) and Section of Neurophysiopathology (F.L.), University of Florence, Viale Morgagni 85, 50134 Florence, Italy; Department of Radiology, University of Pisa, Italy (M.C.); Department of Clinical Neurology, Ospedale Bellaria, University of Bologna, Italy (F.S., R.P., C.A.T.); Department of Neurophysiopathology, Ospedale di Empoli, Italy (M. Macucci); IRCSS Stella Maris, Calambrone, Pisa, Italy (M.T.); and Institute of Genetic Medicine, University of Ferrara, Italy (A.F.). Received April 4, 2001; revision requested May 14; revision received July 23; accepted November 20. Supported by grant No. E444 from Telethon-Italy. Address correspondence to M. Mascalchi.
PURPOSE: To investigate whether proton magnetic resonance (MR) spectroscopy is a useful complement to MR imaging in patients with degenerative ataxia.
MATERIALS AND METHODS: Brain MR imaging and single-voxel proton MR spectroscopy of the right cerebellar hemisphere and pons were performed in 30 patients with sporadic (n = 16) or inherited (n = 14) degenerative ataxia and in 20 healthy control subjects. Several indexes of brainstem and cerebellar atrophy were measured on MR images, as well as the N-acetylaspartate/creatine (NAA/Cr), choline/Cr (Cho/Cr), and myo-inositol/Cr (mI/Cr) ratios in the MR spectra. Differences between patients and subjects were evaluated with the Kruskal-Wallis and Mann-Whitney tests, whereas correlation of clinical, MR imaging, and spectroscopic data was assessed with nonparametric Spearman rank correlation.
RESULTS: Measurements of brainstem and cerebellar atrophy obtained from MR images revealed patients had olivopontocerebellar atrophy (OPCA) (n = 11), spinal atrophy (SA) (n = 8), or corticocerebellar atrophy (CCA) (n = 4). Seven patients did not fulfill the criteria for any group and were considered undefined. In patients with OPCA, the pontine and cerebellar NAA/Cr and Cho/Cr ratios were significantly decreased when compared with those of the control subjects. Pontine and cerebellar NAA/Cr ratios were also significantly reduced in patients with SA and CCA. Five patients with undefined ataxia had a substantial decrease of pontine or cerebellar NAA/Cr ratio when compared with that of the control subjects. In patients with OPCA, the pontine NAA/Cr ratio (but not the atrophy measurements) showed a correlation (P = .04) with disability.
CONCLUSION: MR spectroscopy is a useful complement to MR imaging in patients with degenerative ataxia.
© RSNA, 2002
Index terms: Brain, atrophy, 151.1839, 153.1839 Brainstem, abnormalities, 158.1839 Brainstem, MR, 158.12145 Magnetic resonance (MR), spectroscopy, 158.12145 Spinal cord, diseases, 341.189
This article has been cited by other articles:
![]() |
A. Ginestroni, L. Guerrini, R. D. Nave, C. Tessa, E. Cellini, M.T. Dotti, P. Brunori, N. De Stefano, S. Piacentini, and M. Mascalchi Morphometry and 1H-MR Spectroscopy of the Brain Stem and Cerebellum in Three Patients with Fragile X-Associated Tremor/Ataxia Syndrome AJNR Am. J. Neuroradiol., March 1, 2007; 28(3): 486 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.I. Wallis, P.D. Griffiths, S.J. Ritchie, C.A.J. Romanowski, G. Darwent, and I.D. Wilkinson Proton Spectroscopy and Imaging at 3T in Ataxia-Telangiectasia AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 79 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Harno, S. Heikkinen, M. A. Kaunisto, M. Kallela, A-M. Hakkinen, M. Wessman, M. Farkkila, and N. Lundbom Decreased cerebellar total creatine in episodic ataxia type 2: A 1H MRS study Neurology, February 8, 2005; 64(3): 542 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Griffin, C. K. Cemal, and M. A. Pook Defining a metabolic phenotype in the brain of a transgenic mouse model of spinocerebellar ataxia 3 Physiol Genomics, February 13, 2004; 16(3): 334 - 340. [Abstract] [Full Text] [PDF] |
||||